FEBS Letters has retracted three papers by the Brazilian diabetologist Mario Saad, bringing his total to 18. The now-retracted articles, published between 2005 and 2010, contain doctored images, according to the notices, which read similarly. Here’s one, for the 2005 paper “Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals”:
Over the years, we have written about a number of the sleuths who, on their own time and often at great risks to their careers or finances, have looked for issues in the scientific literature. Here’s a sampling:
WASHINGTON, DC — Lawyers for the National Academy of Sciences have asked a District of Columbia court to dismiss a $10 million defamation suit brought by a Stanford University professor. Mark Jacobson, an engineering professor at Stanford who has published research about the future of renewable energy, alleged he was defamed in a June 2017 … Continue reading PNAS asks D.C. court to dismiss $10 million defamation lawsuit
The São Paulo Research Foundation (FAPESP), a state-level agency in Brazil that funds scientific research, is suing Paty Karoll Picardi, a protégé of Brazilian diabetes researcher Mario Saad. According to a São Paulo Court of Justice website, the reason stated is for “recebimento of bolsa de estudos,“ which translates to “receipt of scholarship.” FAPESP is … Continue reading Brazil research foundation sues scientist over $103k scholarship
Title: Assessment of coronary heart diseases in diabetics in al-Madinah al-Munawarah What Caught Our Notice: We’ve seen researchers dinged for adding authors to papers who didn’t participate in the research, but it’s rare to have a notice say co-author signatures were forged. In a recent retraction, the first two authors said the signatures on the the … Continue reading Caught Our Notice: Wait…we wrote WHAT paper?
A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.” Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free … Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”
A diabetes researcher who sued a publisher to protect several papers from being retracted recently received his 13th, in a prestigious gastroenterology journal. Mario Saad, based at the University of Campinas in São Paulo, Brazil, has had a string of retractions over the past few years, including four in Diabetes after he lost a legal … Continue reading Diabetes researcher who sued to prevent retractions now has 13
A diabetes journal has issued two notices of concern for papers co-authored by a researcher who took another publisher to court after it did the same thing — but ultimately lost. The notices are for two papers co-authored by Mario Saad — who, after losing his legal battle with the American Diabetes Association, has since … Continue reading Journal flags two more papers by diabetes researcher who sued to stop retractions (and now has 12)
A diabetes researcher who once sued a publisher to prevent several retractions has just issued his 12th. The latest retraction, like several others for Mario Saad, appears in the journal Diabetes. Although in the past Saad expended considerable effort to protect four other Diabetes papers from this same fate, the latest retraction was initiated by the authors, citing several duplicated images. … Continue reading Researcher who sued to prevent retractions now has 12
After a publisher learned there may be issues with a 2008 diabetes paper, it asked the author’s university to investigate. The university found evidence of image duplication, and asked the journal to consider correcting the paper. Instead, the journal has retracted it. The backstory involves diabetes researcher Kathrin Maedler, who has one previous retraction, as … Continue reading University suggests journal correct diabetes paper. Publisher retracts it.